Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 8/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 3/20 | 0.42 |
| ▸ | ITGAL | P20701 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TEAD1 | P28347 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.38 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6497183 | 0.91 | ITGAL (0.45) | ENPP2CAPN1ITGALKMT2ANPC1 | |
| SCHEMBL6497179 | 0.91 | ITGAL (0.45) | ENPP2CAPN1ITGALKMT2ANPC1 | |
| SCHEMBL6497665 | 0.91 | SMN1; SMN2 (0.48) | ENPP2CAPN1ITGALKCNH2KMT2A | |
| SCHEMBL6497667 | 0.91 | SMN1; SMN2 (0.48) | ENPP2CAPN1ITGALKCNH2KMT2A | |
| SCHEMBL6495354 | 0.90 | ENPP2 (0.46) | ENPP2CAPN1ITGALKCNH2KMT2A | |
| SCHEMBL6495356 | 0.90 | ENPP2 (0.46) | ENPP2CAPN1ITGALKCNH2KMT2A | |
| SCHEMBL6497914 | 0.86 | CAPN1 (0.44) | ENPP2CAPN1ITGALKMT2ANPC1 | |
| SCHEMBL6497917 | 0.86 | CAPN1 (0.44) | ENPP2CAPN1ITGALKMT2ANPC1 | |
| SCHEMBL6502924 | 0.83 | CAPN1 (0.44) | CAPN1ITGALKMT2ANPC1RAB9A | |
| SCHEMBL6502929 | 0.83 | CAPN1 (0.44) | CAPN1ITGALKMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | claimed |
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |